Sr. Director, US Policy Strategy

The Opportunity:

Reporting to the Head of US Patient Advocacy & Government Affairs, as the Sr. Director, US Policy Strategy, you will lead CSL’s US health policy and market access policy strategy, serving as the company’s principal US policy expert. You will assess legislative and regulatory developments, identify risks and opportunities, develop policy positions, and shape advocacy strategies that support CSL’s business, portfolio, pipeline, and patient access priorities. In this role, you will oversee the full range of federal and state policy issues affecting CSL, including drug pricing reform, government payer and reimbursement policy, 340B, PBM reform, intellectual property, trade, tax, and manufacturing and supply chain policy. You will partner across Government Affairs and Advocacy, Market Access, Legal, Commercial, Medical Affairs, Regulatory Policy, Communications, Finance, Manufacturing/Supply Chain, and US/global Therapeutic Area teams to translate complex policy issues into clear business implications and actionable strategies. You will also represent CSL with policymakers, government agencies, trade associations, industry coalitions, think tanks, and other external stakeholders.You will keep patients and plasma donors central to CSL’s policy work, advancing strategies that support access to innovative therapies, address unmet medical needs, and strengthen CSL’s portfolio across Immunology, Hematology, Cardiovascular and Metabolic, Transplant, and Respiratory.

The expected base salary range for this position at hiring is $297,000- $364,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed location as of the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies, and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

This is a hybrid role, requiring three (3) days of onsite work weekly.

The Role:

Strategic Policy Leadership

• Develop and lead CSL’s federal and state health policy strategy, aligned with corporate, commercial, market access, and therapeutic area priorities.
• Monitor, analyze, and forecast legislative and regulatory developments across the full US policy landscape affecting CSL, including drug pricing reform, Medicare and Medicaid policy, 340B, rebate and PBM reform, intellectual property and patent policy, trade policy, tax policy, and manufacturing and supply chain policy.
• Identify US policy risks and opportunities across CSL’s portfolio and pipeline, and develop strategies to address business, access, reimbursement, and patient impact.
• Lead development of CSL’s US policy positions, advocacy priorities, talking points, policy materials, and executive-ready briefings.
• Serve as the internal subject-matter expert on policy trends affecting CSL’s therapeutic areas, pipeline, commercial operations, payer strategy, and broader business environment.

Market Access, Reimbursement, and Business Strategy

• Shape CSL’s broader market access policy strategy, ensuring policy positions support payer, provider, reimbursement, and patient access objectives across commercial and government channels.
• Analyze policy developments across Medicare Parts A, B, C, and D, Medicaid coverage and pricing, value-based payment agreements, and other government payer policies relevant to CSL’s portfolio.
• Partner with Market Access, Payer Strategy, Commercial, Finance, and other business functions to assess quantitative and qualitative impacts of policy proposals and inform launch, pricing, reimbursement, and access decisions.
• Support business development, M&A, and product strategy decisions with policy risk assessments and strategic policy counsel.

Government and Stakeholder Engagement

• Lead access-focused policy strategy and advocacy with key government policymakers, payers, and influencers, including CMS, HHS, and other relevant federal and state agencies.
• Represent CSL before trade associations, industry coalitions, policy think tanks, cross-company working groups, and other external stakeholders to advance CSL priorities.
• Manage relationships with outside policy consultants and oversee related policy budgets, as appropriate.

External Advocacy and Policy Submissions

• Lead development of comment letters, testimony, position papers, policy submissions, and other advocacy materials in response to proposed rules, legislation, guidance, and other policy developments.
• Develop evidence-based policy arguments and advocacy materials that clearly communicate CSL’s positions and business priorities to policymakers and external stakeholders.
• Track and respond to policy developments affecting market access, reimbursement, intellectual property, trade, tax, manufacturing, supply chain, and patient access.

Cross-Functional and Global Collaboration

…